TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,419
|
32,315
|
33,866 |
| Financial expenses |
0
|
1
|
113 |
| Earnings before taxes |
-2,477
|
491
|
-3,339 |
| EBITDA |
-2,031
|
1,105
|
-2,434 |
| Total assets |
21,161
|
24,458
|
23,424 |
| Current assets |
18,295
|
21,668
|
20,322 |
| Current liabilities |
5,801
|
9,605
|
8,892 |
| Equity capital |
15,190
|
14,686
|
14,195 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
11
|
13
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
71.8%
|
60.0%
|
60.6% |
| Turnover per employee |
2,674
|
2,486
|
2,605 |
| Profit as a percentage of turnover |
-8.4%
|
1.5%
|
-9.9% |
| Return on assets (ROA) |
-11.7%
|
2.0%
|
-13.8% |
| Current ratio |
315.4%
|
225.6%
|
228.5% |
| Return on equity (ROE) |
-16.3%
|
3.3%
|
-23.5% |
| Change turnover |
-3,479
|
-3,954
|
184 |
| Change turnover % |
-11%
|
-11%
|
1% |
| Chg. No. of employees |
-2
|
0
|
1 |
| Chg. No. of employees % |
-15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.